Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aarna USA is a medical device company headquartered in Georgia, specializing in the design and manufacture of biopsy site markers. The company's primary focus is on providing high-quality, cost-effective solutions for breast biopsy procedures, ensuring that biopsy sites are clearly marked for future diagnostic and surgical reference. Their product line, including the Aarna Marker series, features various shapes and materials optimized for visibility under multiple imaging modalities such as ultrasound, mammography, and MRI. Aarna USA serves the radiology and oncology communities by enhancing the precision of follow-up care for patients undergoing breast cancer screening and diagnosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aarna USA.